Bayer-Monsanto has agreed to pay at least $10 billion to settle roughly 100,000 lawsuits from people who claim Roundup® weed-killer caused them to develop non-Hodgkin's lymphoma.
Monsanto will pay a $39.5 million class action settlement for falsely claiming that Roundup weed-killer targets an enzyme that is only found in plants.
A judge in St. Louis delayed a trial over the cancer risks of Bayer's Roundup® weed-killer to give attorneys time to negotiate a settlement.
Young honey bees are being poisoned by glyphosate, the active ingredient in Roundup weed killer and a chemical named as the causative agent in thousands of lawsuits alleging cancer from the herbicide, according to a new study published in the...
Monsanto took a massive financial hit last week as a California jury sided with a former groundskeeper from San Francisco who claims he developed Non-Hodgkin’s lymphoma from using the company’s Roundup weed killer, awarding the man nearly $290 million in...
A jury in California heard testimony that an official at the U.S. Environmental Protection Agency tried to interfere with a federal study on the cancer risks of Monsanto's Roundup weed-killer.
A judge allowed hundreds of lawsuits to move forward against Monsanto for allegedly downplaying the cancer risk of Roundup.
Glyphosate, the active ingredient in Monsanto’s Roundup weed killer, has been declared safe by the European Union (EU), placing future generations in eminent peril by exposing children to a toxic cocktail of pesticides in their food, water, and play areas.
Lobbyists working for Monsanto are banned from entering the European parliament after the company refused to attend a hearing into allegations that it interfered with safety studies on glyphosate, the weed-killer in Roundup.